Frederic Li 27th Lorne Cancer Conference 2015

Abstracts this author is presenting:

• Receptor Tyrosine Kinases differ in their ability to confer resistance to Vemurafenib (PLX4032) treatment in BRAF^V600E melanoma. — Poster Session 1